Literature DB >> 9136836

Inhibitory neurotransmission in lethal spotted mutant mice: a model for Hirschsprung's disease.

S Chakder1, K M McHugh, S Rattan.   

Abstract

BACKGROUND & AIMS: The pathogenesis of Hirschsprung's disease is not well understood. The suitability of the animal model for the unknown pathogenesis of inhibitory neurotransmission in Hirschsprung's disease was investigated.
METHODS: Circular smooth muscle strips from the internal anal sphincter (IAS) and distal colon (2, 6, 8, 16, and 24 mm from the anal verge) from normal and Ls/Ls mice (mice homozygous for the lethal spotting mutation that develop fetal megacolon after aganglionosis of the terminal colon) were prepared to record changes in isometric tensions in response to different agents and nonadrenergic, noncholinergic nerve stimulation by electrical field stimulation.
RESULTS: Bethanechol was used to produce contraction of the smooth muscle strips of distal colon to record a decrease in the tension. Conversely, the IAS smooth muscle strips developed spontaneous tone. In the normal homozygous mice, electrical field stimulation caused a biphasic response, an initial decrease followed by an after-contraction, whereas in Ls/Ls mice, the predominant response was contraction. All smooth muscle strips from normal and Ls/Ls mice produced relaxation in response to sodium nitroprusside and vasoactive intestinal polypeptide.
CONCLUSIONS: Ls/Ls mice may serve as an appropriate animal model to investigate the pathogenesis of the inhibitory neurotransmission in Hirschsprung's disease in the distal colon and IAS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136836     DOI: 10.1016/s0016-5085(97)70039-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Increased smooth muscle contractility of intestine in the genetic null of the endothelin ETB receptor: a rat model for long segment Hirschsprung's disease.

Authors:  K-J Won; S Torihashi; M Mitsui-Saito; M Hori; K Sato; T Suzuki; H Ozaki; H Karaki
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  BDNF augments rat internal anal sphincter smooth muscle tone via RhoA/ROCK signaling and nonadrenergic noncholinergic relaxation via increased NO release.

Authors:  Arjun Singh; Ipsita Mohanty; Jagmohan Singh; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

3.  COX-1 vs. COX-2 as a determinant of basal tone in the internal anal sphincter.

Authors:  Márcio A F de Godoy; Neeru Rattan; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

4.  Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function.

Authors:  Jagmohan Singh; Sidney Cohen; Vaibhav Mehendiratta; Fabian Mendoza; Sergio A Jimenez; Anthony J Dimarino; Satish Rattan
Journal:  Gastroenterology       Date:  2012-08-01       Impact factor: 22.682

5.  Evidence for the presence and release of BDNF in the neuronal and non-neuronal structures of the internal anal sphincter.

Authors:  Arjun Singh; Jagmohan Singh; Satish Rattan
Journal:  Neurogastroenterol Motil       Date:  2021-02-24       Impact factor: 3.960

6.  The molecular basis of the genesis of basal tone in internal anal sphincter.

Authors:  Cheng-Hai Zhang; Pei Wang; Dong-Hai Liu; Cai-Ping Chen; Wei Zhao; Xin Chen; Chen Chen; Wei-Qi He; Yan-Ning Qiao; Tao Tao; Jie Sun; Ya-Jing Peng; Ping Lu; Kaizhi Zheng; Siobhan M Craige; Lawrence M Lifshitz; John F Keaney; Kevin E Fogarty; Ronghua ZhuGe; Min-Sheng Zhu
Journal:  Nat Commun       Date:  2016-04-22       Impact factor: 14.919

7.  Esophageal muscle physiology and morphogenesis require assembly of a collagen XIX-rich basement membrane zone.

Authors:  Hideaki Sumiyoshi; Niv Mor; Sui Y Lee; Stephen Doty; Scott Henderson; Shizuko Tanaka; Hidekatsu Yoshioka; Satish Rattan; Francesco Ramirez
Journal:  J Cell Biol       Date:  2004-08-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.